PBAC Public Summary Documents – May 2021

Page last updated: 10 September 2021

Public Summary Documents relating to the May 2021 PBAC meeting.

• Encorafenib Tablet 50 mg, Tablet 75 mg, Braftovi®
• Elexacaftor+ tezacaftor + ivacaftor: Pack containing 56 tablets of elexacaftor 100 mg with tezacaftor 50 mg and ivacaftor 75 mg and 28 tablets of ivacaftor 150 mg; Trikafta®
• Onasemnogene abeparvovec: Solution for injection, customised based on patient weight; Zolgensma®
• Tetracosactide: Compound depot injection 1 mg in 1 mL; Synacthen®